Food and Chemotherapy Effects on Etoposide
Author Information
Author(s): V.J. Harvey, M.L. Slevin, S.P. Joel, A. Johnston, P.F.M. Wrigley
Primary Institution: Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's and Hackney Hospitals
Hypothesis
Does food or concurrent chemotherapy affect the bioavailability of oral etoposide?
Conclusion
Food and concurrent chemotherapy do not significantly affect the bioavailability of oral etoposide.
Supporting Evidence
- Patients showed considerable variation in etoposide bioavailability.
- Food did not significantly interfere with etoposide bioavailability.
- Patients can safely take etoposide with other chemotherapy agents.
Takeaway
This study found that patients don't need to fast before taking etoposide, a cancer drug, and can take it with other treatments.
Methodology
The study involved 11 patients receiving chemotherapy for small cell lung carcinoma, assessing the effects of food and concurrent chemotherapy on etoposide bioavailability through pharmacokinetic analysis.
Limitations
The study had a small sample size and focused only on specific chemotherapy regimens.
Participant Demographics
Patients were ambulant with normal bone marrow, hepatic, and renal function, and no gastrointestinal disturbances.
Want to read the original?
Access the complete publication on the publisher's website